Diabetes drug rybelsus tested in everyday life: does it really work?
NCT ID NCT05230615
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study looked at how well the diabetes pill Rybelsus (oral semaglutide) controls blood sugar in adults with type 2 diabetes in Italy. Researchers tracked 458 people over 8-10 months, measuring changes in blood sugar levels and body weight. The goal was to see how the drug performs in real-world conditions, not a strict lab setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS MultiMedica
Sesto San Giovanni, Italy
-
Master Centre for Italy
Rome, 00144, Italy
Conditions
Explore the condition pages connected to this study.